Advanced gastric and esophageal malignant tumor complicated by chylous ascites: A case report

Chylous ascites caused by lymphatic vessel obstruction due to compression from advanced gastric and esophageal malignant tumors is relatively rare in clinical practice. It is often accompanied by malnutrition, hypoproteinemia, and a poor prognosis. We report a patient with an advanced gastric and esophageal malignant tumor complicated by chylous ascites. Management focused on symptom control and individualized nutritional support, including intravenous medium-chain triglyceride emulsion together with enteral nutritional emulsion administered through a nasoenteric tube, paracentesis for symptomatic relief, and supportive measures. Although the underlying malignancy determined the overall prognosis, and the patient died in May 2023, the interventions provided temporary improvement in symptoms and nutritional status. This case highlights the importance of early recognition of chylous ascites and of prioritizing symptom relief, individualized nutritional strategies, and palliative goals of care in patients with advanced malignancy.

Authors

Publication Details

Journal
Tumor Discovery
Published
2025-09-26
DOI
https://doi.org/10.36922/td025330083
Primary Topic
Lymphatic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advanced gastric and esophageal malignant tumor complicated by chylous ascites: A case report

Jialing Shi, Guanwen Gong, Xiaochun Zhang
Tumor Discovery
Lymphatic Disorders and Treatments
article

Advanced gastric and esophageal malignant tumor complicated by chylous ascites: A case report

Jialing Shi, Guanwen Gong, Xiaochun Zhang
article en

Abstract

Chylous ascites caused by lymphatic vessel obstruction due to compression from advanced gastric and esophageal malignant tumors is relatively rare in clinical practice. It is often accompanied by malnutrition, hypoproteinemia, and a poor prognosis. We report a patient with an advanced gastric and esophageal malignant tumor complicated by chylous ascites. Management focused on symptom control and individualized nutritional support, including intravenous medium-chain triglyceride emulsion together with enteral nutritional emulsion administered through a nasoenteric tube, paracentesis for symptomatic relief, and supportive measures. Although the underlying malignancy determined the overall prognosis, and the patient died in May 2023, the interventions provided temporary improvement in symptoms and nutritional status. This case highlights the importance of early recognition of chylous ascites and of prioritizing symptom relief, individualized nutritional strategies, and palliative goals of care in patients with advanced malignancy.

Tumor DiscoveryVol. 5(1)
Openalex Percentile: Top 58%
Lymphatic Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Advanced gastric and esophageal malignant tumor complicated by chylous ascites: A case report — Jialing Shi, Guanwen Gong, et al. · Tumor Discovery (2025) | TGRS Research Map | TGRS